AA
Amit Agrawal
About Amit Agrawal
Data last updated:
Amit Agrawal is a Whole-Time Director at Pace Biotech Private Limited (since 2023), Whole-Time Director at Ravetaara Diabetics Private Limited (since 2023) and Director at Tripti Traders Pvt Ltd (since 2005), and holds 3 more current directorships. The companies operate in Real Estate and Construction, Healthcare and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹9.02 Cr; the largest is Pace Biotech Private Limited at ₹5.13 Cr (FY 2025). Earlier, Amit Agrawal was a Director at Katni Granimarmo Private Limited (2005–2009) and Designated Partner at Sweta Apartment Llp (from 2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pace Biotech Private Limited U24233WB1991PTC053485 | Whole-Time Director | 30 Mar 2023 | 1991 | ₹5.13 Cr (FY 2025) | Active |
| Ravetaara Diabetics Private Limited U85110WB2004PTC210457 | Whole-Time Director | 30 Mar 2023 | 2004 | ₹3.62 Cr (FY 2025) | Active |
| Tripti Traders Pvt Ltd U51909WB1986PTC040408 | Director | 21 Feb 2005 | 1986 | ₹23.3 Lakh (FY 2025) | Active |
| Solar Trading & Investment Ltd U65993WB1940PLC010118 | Director | 08 Jun 2005 | 1940 | ₹3 Lakh (FY 2024) | Active |
 Indivac Healthcare Private Limited U85100WB2012PTC186512 | Director | 16 Jul 2015 | 2012 | ₹28,781 (FY 2023) | Active |
| Gochem Speciality Chemicals Private Limited U24299WB2021PTC245968 | Director | 24 Jun 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Katni Granimarmo Private Limited U14101RJ2003PTC018112 | Director | 27 Jul 2005 | 2003 | Active | |
| Sweta Apartment Llp AAS-8507 | Designated Partner | 11 Jul 2020 | 2020 | Strike Off | |
| Leopin Enterprise Llp AAY-9882 | Designated Partner | 12 Oct 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Amit Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Archana Agrawal | 00963206 | Pace Biotech Private Limited | Director |
| Kailash Prasad Agarwal | 00964069 | Pace Biotech Private Limited , Indivac Healthcare Private Limited and 1 more | Director |
| Prakash Devi Agrawal | 00963561 | Ravetaara Diabetics Private Limited | Director |
| Shambhu Nath Choubey | 03047740 | Ravetaara Diabetics Private Limited , Tripti Traders Pvt Ltd and 1 more | Director |
| Vijay Prakash Mishra | 00559513 | Tripti Traders Pvt Ltd | Director |
| Aditya Maheswari | 00474349 | Solar Trading & Investment Ltd | Director |
| Sonam Maheswari | 07431219 | Solar Trading & Investment Ltd | Director |
| Kanchan Goyel | 08103793 | Gochem Speciality Chemicals Private Limited | Director |
| Vikin Goyel | 00361782 | Gochem Speciality Chemicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Agrawal
Amit Agrawal currently holds 6 directorships: Pace Biotech Private Limited (Whole-Time Director, since 30 Mar 2023, revenue ₹5.13 Cr (FY 2025)); Ravetaara Diabetics Private Limited (Whole-Time Director, since 30 Mar 2023, revenue ₹3.62 Cr (FY 2025)); Tripti Traders Pvt Ltd (Director, since 21 Feb 2005, revenue ₹23.3 Lakh (FY 2025)); Solar Trading & Investment Ltd (Director, since 08 Jun 2005, revenue ₹3 Lakh (FY 2024)); Indivac Healthcare Private Limited (Director, since 16 Jul 2015, revenue ₹28,781 (FY 2023)); and 1 more.
Amit Agrawal was first appointed on 21 Feb 2005 as Director at Tripti Traders Pvt Ltd. The most recent appointment on record is 30 Mar 2023 at Ravetaara Diabetics Private Limited.
The 5 current companies of Amit Agrawal that report revenue have a combined latest revenue of ₹9.02 Cr: Pace Biotech Private Limited ₹5.13 Cr (FY 2025); Ravetaara Diabetics Private Limited ₹3.62 Cr (FY 2025); Tripti Traders Pvt Ltd ₹23.3 Lakh (FY 2025); Solar Trading & Investment Ltd ₹3 Lakh (FY 2024); Indivac Healthcare Private Limited ₹28,781 (FY 2023).
Amit Agrawal held 3 earlier board appointments: Katni Granimarmo Private Limited (Director, 27 Jul 2005 to 08 Jun 2009); Sweta Apartment Llp (Designated Partner, from 11 Jul 2020); Leopin Enterprise Llp (Designated Partner, from 12 Oct 2021).
The current boards of Amit Agrawal's companies include Archana Agrawal (Pace Biotech Private Limited), Kailash Prasad Agarwal (Pace Biotech Private Limited), Prakash Devi Agrawal (Ravetaara Diabetics Private Limited), Shambhu Nath Choubey (Ravetaara Diabetics Private Limited), Vijay Prakash Mishra (Tripti Traders Pvt Ltd), Aditya Maheswari (Solar Trading & Investment Ltd), among others.